Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-03-055429
Filing Date
2003-09-29
Accepted
2003-09-29 17:10:45
Documents
8
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 FISCAL YEAR ENDING JUNE 30, 2003 d10k.htm 10-K 852101
3 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 6168
4 CONSENT OF INDEPENDENT ACCOUNTANTS dex231.htm EX-23.1 1939
5 CERTIFICATION PURSUANT TO SECTION 302 dex311.htm EX-31.1 6838
6 CERTIFICATION PURSUANT TO SECTION 302 dex312.htm EX-31.2 6844
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 4526
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 4255
9 GRAPHIC g54582g88t92.jpg GRAPHIC 135948
  Complete submission text file 0001193125-03-055429.txt   1021383
Mailing Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324
Business Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324 9542338377
VIRAGEN INTERNATIONAL INC (Filer) CIK: 0000785081 (see all company filings)

EIN.: 112788282 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-17827 | Film No.: 03915616
SIC: 2836 Biological Products, (No Diagnostic Substances)